Janux Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Janux Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q2 2024.
  • Janux Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 52.2M shares, a 13.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 52.2M +6.03M +13.1% Aug 5, 2024 10-Q 2024-08-07
Q1 2024 51.7M +9.83M +23.5% Mar 6, 2024 10-K 2024-03-08
Q3 2023 46.2M +4.51M +10.8% Nov 3, 2023 10-Q 2023-11-07
Q2 2023 46.1M +4.48M +10.7% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 41.8M +210K +0.51% Mar 8, 2023 10-K 2023-03-10
Q3 2022 41.7M +51.5K +0.12% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 41.7M +51.5K +0.12% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 41.6M Mar 16, 2022 10-K 2022-03-18
Q3 2021 41.6M Nov 5, 2021 10-Q 2021-11-09
Q2 2021 41.6M Aug 6, 2021 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.